Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
UCLA Pfleger Liver Institute
mi
from
Los Angeles, CA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
UCLA Pfleger Liver Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Georgetown University Hospital
mi
from
Washington,
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Florida
mi
from
Gainesville, FL
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Miami
mi
from
Miami, FL
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Piedmont Atlanta Hospital
mi
from
Atlanta, GA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Piedmont Atlanta Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Rush University Medical Center
mi
from
Chicago, IL
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Chicago Medicine
mi
from
Chicago, IL
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Chicago Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Indiana University
mi
from
Indianapolis, IN
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Louisville
mi
from
Louisville, KY
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Tulane Health Science Center
mi
from
New Orleans, LA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Tulane Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Ochsner Clinic
mi
from
New Orleans, LA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Ochsner Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Henery Ford Health System
mi
from
Detroit, MI
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Henery Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Rutgers New Jersey Medical School
mi
from
Newark, NJ
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Rutgers New Jersey Medical School
mi
from
Newark, NJ
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Columbia University Medical Center
mi
from
New York, NY
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Cincinnati Physicians Company, LLC
mi
from
Cincinnati, OH
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Cincinnati Physicians Company, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Pennsylvania Milton Hershey Hospital
mi
from
Philadelphia, PA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Pennsylvania Milton Hershey Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Temple University Hospital
mi
from
Philadelphia, PA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Albert Einstein Medical Center
mi
from
Philadelphia, PA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Albert Einstein Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Liver Associates of Texas
mi
from
Houston, TX
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Liver Associates of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
VAMC/Baylor College of Medicine
mi
from
Houston, TX
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
VAMC/Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Utah
mi
from
Salt Lake City, UT
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Bon Secours Mary Immaculate Hospital
mi
from
Newport News, VA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Bon Secours Mary Immaculate Hospital
mi
from
Newport News, VA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Bon Secours St. Mary's Hospital of Richmond, Inc.
mi
from
Richmond, VA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Bon Secours St. Mary's Hospital of Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Mcguire Dvamc
mi
from
Richmond, VA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Johns Hopkins Sibley Memorial Hospital
mi
from
Washington,
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Johns Hopkins Sibley Memorial Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
John Hopkins Hospital
mi
from
Baltimore, MD
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
John Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated:  4/9/2018
Saint Louis University
mi
from
Saint Louis, MO
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Status: Enrolling
Updated: 4/9/2018
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Pilot Investigation of 18F-FES PET/CT Imaging of Desmoid Tumors
Status: Enrolling
Updated:  4/9/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Pilot Investigation of 18F-FES PET/CT Imaging of Desmoid Tumors
Status: Enrolling
Updated: 4/9/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Development of 'Emma'--a Pediatric IBD Quiz
Development of an Electronic Pediatric Inflammatory Bowel Disease Quiz
Status: Enrolling
Updated:  4/12/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Development of 'Emma'--a Pediatric IBD Quiz
Development of an Electronic Pediatric Inflammatory Bowel Disease Quiz
Status: Enrolling
Updated: 4/12/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Development of 'Emma'--a Pediatric IBD Quiz
Development of an Electronic Pediatric Inflammatory Bowel Disease Quiz
Status: Enrolling
Updated:  4/12/2018
Oklahoma University Medical Center
mi
from
Oklahoma City, OK
Development of 'Emma'--a Pediatric IBD Quiz
Development of an Electronic Pediatric Inflammatory Bowel Disease Quiz
Status: Enrolling
Updated: 4/12/2018
Oklahoma University Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
A Phase 1, Open-Label Study to Characterize the Pharmacokinetics and Safety of a Single Oral Dose of GBT440 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  4/17/2018
University of Miami
mi
from
Miami, FL
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
A Phase 1, Open-Label Study to Characterize the Pharmacokinetics and Safety of a Single Oral Dose of GBT440 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 4/17/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
A Phase 1, Open-Label Study to Characterize the Pharmacokinetics and Safety of a Single Oral Dose of GBT440 in Subjects With Hepatic Impairment
Status: Enrolling
Updated:  4/17/2018
OCRC
mi
from
Orlando, FL
Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment
A Phase 1, Open-Label Study to Characterize the Pharmacokinetics and Safety of a Single Oral Dose of GBT440 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 4/17/2018
OCRC
mi
from
Orlando, FL
Click here to add this to my saved trials
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Status: Enrolling
Updated:  4/18/2018
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Status: Enrolling
Updated: 4/18/2018
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Status: Enrolling
Updated:  4/18/2018
Children's Hopsitals and Clinics of Minnesota
mi
from
Saint Paul, MN
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
Status: Enrolling
Updated: 4/18/2018
Children's Hopsitals and Clinics of Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated:  4/19/2018
Montefiore's Community Clinics (Montefiore Medical Group)
mi
from
Bronx, NY
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Montefiore's Community Clinics (Montefiore Medical Group)
mi
from
Bronx, NY
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated:  4/19/2018
Albert Einstein College of Medicine Division of Substance Abuse clinics
mi
from
Bronx, NY
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Albert Einstein College of Medicine Division of Substance Abuse clinics
mi
from
Bronx, NY
Click here to add this to my saved trials
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated:  4/19/2018
Montefiore Infectious Disease Clinic
mi
from
Bronx, NY
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
A Randomized Trial of an Abstinence-reinforcing Contingency Management Intervention to Suppress HIV Viral Load
Status: Enrolling
Updated: 4/19/2018
Montefiore Infectious Disease Clinic
mi
from
Bronx, NY
Click here to add this to my saved trials
Pilot Test of a Community-based Buprenorphine Treatment Intervention
Development of a Community-based Buprenorphine Treatment Intervention
Status: Enrolling
Updated:  4/19/2018
Washington Heights Corner Project
mi
from
New York, NY
Pilot Test of a Community-based Buprenorphine Treatment Intervention
Development of a Community-based Buprenorphine Treatment Intervention
Status: Enrolling
Updated: 4/19/2018
Washington Heights Corner Project
mi
from
New York, NY
Click here to add this to my saved trials
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  4/19/2018
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 4/19/2018
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  4/19/2018
Montefiore Medical Center
mi
from
Bronx, NY
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 4/19/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated:  4/19/2018
Concorde Medical Group
mi
from
New York, NY
Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
Multicenter, Randomized, Double-blinded, Placebo-controlled Trial of Fecal Microbiota Transplantation (FMT) for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling
Updated: 4/19/2018
Concorde Medical Group
mi
from
New York, NY
Click here to add this to my saved trials
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Status: Enrolling
Updated:  4/19/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
Status: Enrolling
Updated: 4/19/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  4/20/2018
Precision Research Institute, LLC
mi
from
San Diego, CA
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 4/20/2018
Precision Research Institute, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  4/20/2018
The University of California, San Diego
mi
from
La Jolla, CA
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 4/20/2018
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated:  4/20/2018
South Denver Gastroenterology
mi
from
Lone Tree, CO
Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
A Phase IIb, Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Dose-Ranging Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-945429 in Subjects With Moderate to Severe Crohn's Disease
Status: Enrolling
Updated: 4/20/2018
South Denver Gastroenterology
mi
from
Lone Tree, CO
Click here to add this to my saved trials